Works matching IS 17528054 AND DT 2022 AND VI 15 AND IP 2
Results: 32
Expression of Concern: Liu, X., Zhong, L., Li, P., & Zhao, P. MicroRNA‐100 Enhances Autophagy and Suppresses Migration and Invasion of Renal Cell Carcinoma Cells via Disruption of NOX4‐Dependent mTOR Pathway, Clin. Trans. Sci. https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12798
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 576, doi. 10.1111/cts.13217
- Publication type:
- Article
Response to "Wearable Remote Monitoring and COVID‐19".
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 296, doi. 10.1111/cts.13191
- By:
- Publication type:
- Article
Wearable remote monitoring and COVID‐19.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 295, doi. 10.1111/cts.13190
- By:
- Publication type:
- Article
Predictive approaches in inflammatory bowel disease.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 293, doi. 10.1111/cts.13179
- Publication type:
- Article
Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 558, doi. 10.1111/cts.13176
- By:
- Publication type:
- Article
Artificial intelligence in clinical and translational science: Successes, challenges and opportunities.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 309, doi. 10.1111/cts.13175
- By:
- Publication type:
- Article
Effect of renal impairment on the pharmacokinetics and safety of dorzagliatin, a novel dual‐acting glucokinase activator.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 548, doi. 10.1111/cts.13174
- By:
- Publication type:
- Article
Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 535, doi. 10.1111/cts.13173
- By:
- Publication type:
- Article
Adapting regulatory drug‐drug interaction guidance to design clinical pharmacokinetic natural product‐drug interaction studies: A NaPDI Center recommended approach.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 322, doi. 10.1111/cts.13172
- By:
- Publication type:
- Article
Incidental findings in UK healthy volunteers screened for a COVID‐19 vaccine trial.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 524, doi. 10.1111/cts.13170
- By:
- Publication type:
- Article
No implication of HIV coinfection on the plasma exposure to rifampicin, pyrazinamide, and ethambutol in tuberculosis patients.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 514, doi. 10.1111/cts.13169
- By:
- Publication type:
- Article
Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 501, doi. 10.1111/cts.13168
- By:
- Publication type:
- Article
Pharmacokinetics and safety of cenobamate, a novel antiseizure medication, in healthy Japanese, and an ethnic comparison with healthy non‐Japanese.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 490, doi. 10.1111/cts.13167
- By:
- Publication type:
- Article
Model‐informed assessment of ethnic sensitivity and dosage justification for Asian populations in the global clinical development and use of cladribine tablets.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 297, doi. 10.1111/cts.13166
- By:
- Publication type:
- Article
The efficacy and safety of the short‐term combination therapy with ticagrelor and PPIs or H2RA in patients with acute STEMI who underwent emergency PCI.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 477, doi. 10.1111/cts.13165
- By:
- Publication type:
- Article
Dose‐dependent inactivation of airway tryptase with a novel dissociating anti‐tryptase antibody (MTPS9579A) in healthy participants: A randomized trial.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 451, doi. 10.1111/cts.13163
- By:
- Publication type:
- Article
Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168).
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 442, doi. 10.1111/cts.13162
- By:
- Publication type:
- Article
Utilization of physiologically‐based pharmacokinetic model to assess disease‐mediated therapeutic protein‐disease‐drug interaction in immune‐mediated inflammatory diseases.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 464, doi. 10.1111/cts.13164
- By:
- Publication type:
- Article
Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 422, doi. 10.1111/cts.13160
- By:
- Publication type:
- Article
Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 433, doi. 10.1111/cts.13161
- By:
- Publication type:
- Article
Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 409, doi. 10.1111/cts.13159
- By:
- Publication type:
- Article
Population pharmacokinetic/pharmacodynamic assessment of imipenem/cilastatin/relebactam in patients with hospital‐acquired/ventilator‐associated bacterial pneumonia.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 396, doi. 10.1111/cts.13158
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first‐in‐human and first‐in‐patient trials.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 384, doi. 10.1111/cts.13157
- By:
- Publication type:
- Article
Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 371, doi. 10.1111/cts.13154
- By:
- Publication type:
- Article
Evaluation of the potential drug interactions mediated through P‐gp, OCT2, and MATE1/2K with filgotinib in healthy subjects.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 361, doi. 10.1111/cts.13152
- By:
- Publication type:
- Article
Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 353, doi. 10.1111/cts.13151
- By:
- Publication type:
- Article
A phase I study to evaluate the safety, tolerability, pharmacodynamic and pharmacokinetic profiles of ocular GLH8NDE in healthy male adults.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 343, doi. 10.1111/cts.13150
- By:
- Publication type:
- Article
First‐in‐human study of milvexian, an oral, direct, small molecule factor XIa inhibitor.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 330, doi. 10.1111/cts.13148
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 289, doi. 10.1111/cts.13092
- Publication type:
- Article
Retraction: Huang, L., Wang, L., Wang, L., Wu, Z., Jiang, F., Li, Q., & Wang, S. MicroRNA let‐7b Inhibits Proliferation and Induces Apoptosis of Castration‐Resistant Prostate Cancer Cells by Blocking the Ras/Rho Signaling Pathway via NRAS, Clin. Trans. Sci. https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12743
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 578, doi. 10.1111/cts.13060
- Publication type:
- Article
Retraction Statement: Wang, J., Yang, Z., Liu, S., Zhang, L., & Zhao, Y. Silencing of Exosomal miR‐296‐5p Derived from Endothelial Progenitor Cells Enhances Thrombolysis and Recanalization in Deep Vein Thrombosis, Clin. Trans. Sci. https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.12799
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 577, doi. 10.1111/cts.13054
- Publication type:
- Article
MicroRNA‐100 Enhances Autophagy and Suppresses Migration and Invasion of Renal Cell Carcinoma Cells via Disruption of NOX4‐Dependent mTOR Pathway.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 2, p. 567, doi. 10.1111/cts.12798
- By:
- Publication type:
- Article